Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2496)
All Articles published online
|
Publishing Process of This Article
|
Jul 16, 2024 (publication date) through Aug 19, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ji XZ, Liu ZD, Ye YP, Li Q, Liu XJ, Zhou MH, Jin Y. Advanced Lung Adenocarcinoma with EGFR 19-del Mutation Transformed into SCC after EGFR-tyrosine Kinase inhibitors Treatment: A Case report. World J Clin Cases 2024; 12(20): 4405-4411 [PMID: 39015891 DOI: 10.12998/wjcc.v12.i20.4405] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i20/4405.htm |
| Number | Citing Articles |
| 1 |
Mengli Qiu, Peiwen Guo, Jieheng Lin, Sisi Wang, Wenping Wang, Jianying Yang, Zhongming Huang, Yang Cao. A Rare Histologic Transformation from EGFR-Positive Lung Adenocarcinoma to EGFR-Negative Squamous Cell Carcinoma After EGFR-TKIs Resistance: A Case Report. OncoTargets and Therapy 2025; : 803 doi: 10.2147/OTT.S513879
|
| 2 |
Ruo-Bing Qi, Zheng-Hao Wu. Advanced lung adenocarcinoma with <i>EGFR</i> 19-del mutation transforms into squamous cell carcinoma after <i>EGFR</i> tyrosine kinase inhibitor treatment. World Journal of Clinical Cases 2024; 12(32): 6543-6546 doi: 10.12998/wjcc.v12.i32.6543
|